Alexandre Pons-Bennaceur Selected Research

Tuberous Sclerosis (Bourneville's Disease)

1/2023	Development of a Dihydroquinoline-Pyrazoline GluN2C/2D-Selective Negative Allosteric Modulator of the N-Methyl-d-aspartate Receptor.
1/2019	Diadenosine-Polyphosphate Analogue AppCH2ppA Suppresses Seizures by Enhancing Adenosine Signaling in the Cortex.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alexandre Pons-Bennaceur Research Topics

Disease

2	Tuberous Sclerosis (Bourneville's Disease) 01/2023 - 01/2019
2	Epilepsy (Aura) 01/2023 - 01/2019
1	Brain Injuries (Brain Injury) 01/2023
1	Nervous System Diseases (Neurological Disorders) 01/2023
1	Parkinson Disease (Parkinson's Disease) 01/2023
1	Seizures (Absence Seizure) 01/2019
1	Autism Spectrum Disorder 01/2019
1	Drug Resistant Epilepsy 01/2019
1	Brain Diseases (Brain Disorder) 01/2019

Drug/Important Bio-Agent (IBA)

2	trans-sodium crocetinate (crocetin)IBA 01/2023 - 01/2019
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2023
1	PolyphosphatesIBA 01/2019
1	diadenosine- 5',5'''- P(1),P(4)- (beta,beta'- methylene)tetraphosphonateIBA 01/2019
1	Adenosine (Adenocard)FDA LinkGeneric 01/2019
1	diadenosine tetraphosphateIBA 01/2019

Therapy/Procedure

1	Cesarean Section (Caesarean Section) 01/2019